Agios Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Agios Pharmaceuticals has a total shareholder equity of $743.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $849.7M and $105.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$597.99m |
Equity | US$743.92m |
Total liabilities | US$105.79m |
Total assets | US$849.71m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0HB0's short term assets ($663.6M) exceed its short term liabilities ($51.7M).
Long Term Liabilities: 0HB0's short term assets ($663.6M) exceed its long term liabilities ($54.1M).
Debt to Equity History and Analysis
Debt Level: 0HB0 is debt free.
Reducing Debt: 0HB0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0HB0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0HB0 has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 0.4% each year.